Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
10.7%
% of IBB's 261 holdings also in IBRN
64.9%
% of IBRN's 51 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 2.7% | 4.2% | 2.7% |
 |
BIOGEN IDEC INC | 2.1% | 4.2% | 2.1% |
|
INTRA-CELLULAR THERAPIES INC | 1.3% | 6.8% | 1.3% |
|
NEUROCRINE BIOSCIENCES INC | 1.1% | 3.9% | 1.1% |
|
SAREPTA THERAPEUTICS INC | 0.9% | 3.5% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IBRN
|
GILEAD SCIENCES INC | 10.6% |
|
AMGEN INC | 9.6% |
|
VERTEX PHARMACEUTICALS INC | 8.7% |
|
REGENERON PHARMACEUTICALS | 7.3% |
|
IQVIA HOLDINGS INC | 3.4% |
|
ALNYLAM PHARMACEUTICALS INC | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.6% |
|
WATERS CORP | 2.3% |
 |
BIONTECH SE SPONSORED ADR | 2.0% |
|
NATERA INC | 1.7% |
IBB Underweight Relative to IBRN
|
INTRA-CELLULAR THERAPIES INC | -5.6% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -4.5% |
|
PTC THERAPEUTICS INC | -4.4% |
|
CATALYST PHARMACEUTICAL PART | -4.4% |
 |
ALKERMES PLC | -4.3% |
|
ACADIA PHARMACEUTICALS INC | -4.2% |
|
SUPERNUS PHARMACEUTICALS INC | -3.8% |
|
INTEGRA LIFESCIENCES HOLDING | -3.7% |
|
EDGEWISE THERAPEUTICS, INC. | -3.6% |
|
SCHOLAR ROCK HOLDING CORP. | -3.4% |